The PURE Act amends federal drug laws to eliminate purity-based sentencing thresholds for methamphetamine prosecutions. Currently, federal mandatory minimum sentences for methamphetamine trafficking are triggered by the drug's purity level—a requirement that forces federal and state crime laboratories to conduct expensive testing. The bill removes these purity requirements, allowing prosecution based on any detectable amount of methamphetamine instead. The legislation is motivated by the fact that domestic methamphetamine production has collapsed (down from 23,703 clandestine lab seizures in 2004 to 34 in 2024), while Mexican cartels now supply nearly pure methamphetamine (averaging 95 percent purity in 2024 versus 50 percent in 1988), making the historical rationale for purity-based sentencing distinctions obsolete. The bill directs the U.S. Sentencing Commission to review methamphetamine sentencing guidelines to ensure they remain sufficiently stringent while potentially adding enhancements for cases involving multiple victims, weapons, or deaths. The legislation aims to save federal and state laboratory resources while maintaining tough penalties for methamphetamine trafficking.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.